Researchers have discovered that intestinal mast cells trigger severe food allergies by producing leukotrienes rather than the histamine traditionally associated with allergic reactions.
A New Understanding of Gut-Based Anaphylaxis
For decades, medical professionals operated under the assumption that anaphylaxis followed a uniform path throughout the body, primarily driven by histamine released from mast cells. However, Arizona State University researchers, collaborating with teams from Yale and other institutions, have identified that the gut handles allergens differently. When food is ingested, specialized mast cells in the intestinal lining do not rely on histamine as the primary driver of the reaction.
“Our study shows that when allergens are ingested, a specialized set of mast cells in the gut don’t release histamine — instead, they produce lipid-based molecules called leukotrienes. These molecules, rather than histamine, trigger anaphylaxis in the gastrointestinal tract.”
Esther Borges Florsheim, researcher, Arizona State University
These lipid-based molecules, known as cysteinyl leukotrienes, are already well-documented for their role in constricting airways during asthma attacks.
The Rise of Alpha-Gal Syndrome
While gut-based allergy research seeks to address immediate reactions, another form of food allergy is seeing a rapid increase in prevalence in Australia: alpha-gal syndrome (AGS). Unlike traditional food allergies, AGS is an immune reaction to a sugar molecule—galactose-alpha-1,3-galactose—found in mammalian meat, often triggered by a tick bite.
In Australia, the Commonwealth Scientific and Industrial Research Organisation (CSIRO) reports that cases are climbing by approximately 22 per cent annually since 2020.
Because alpha-gal symptoms typically emerge three to six hours after consumption, many patients struggle to link their illness to the food they ate.
Early Life Factors and Immune Tolerance
The quest to understand why allergies develop has shifted toward early-life exposures and the role of the microbiome. A large-scale Swedish register study covering one million births between 2001 and 2012 found that children born via caesarean section faced a 20 per cent higher relative risk of developing a food allergy compared to those born vaginally. Experts hypothesize that this is linked to the lack of exposure to the mother’s bacterial flora during a natural birth.
Conversely, the study highlighted that extremely preterm infants experienced a 26 per cent relative risk decrease in developing food allergies.
| Condition | Primary Trigger | Key Characteristic |
|---|---|---|
| Alpha-Gal Syndrome | Tick bites | Delayed reaction (3-6 hours) |
| IgE-Mediated Allergy | Food ingestion | Rapid reaction |
| Hay Fever | Pollen exposure | Upper airway inflammation |
For parents, the guidance on introducing allergenic foods has shifted significantly. Once advised to avoid eggs, fish, and nuts until age one to two, current clinical findings suggest that early and regular introduction of these foods can actually reduce the risk of developing an allergy.
Precision Treatments and Future Diagnostics
Current management for food allergies relies heavily on avoidance and emergency epinephrine, but the medical community is actively pursuing more targeted therapies. Beyond the potential for asthma drugs to treat gut-based reactions, researchers are exploring ways to train the immune system to neutralize its response. A team from the University of Toulouse in France presented a treatment that fights off anaphylactic shock in mice using a vaccine to battle Immunoglobulin E (IgE).
As research continues into the specific immune pathways of the gut, the hope is for a new generation of non-invasive, highly accurate diagnostic methods that can identify specific allergens before a life-threatening reaction occurs. Always consult your healthcare provider for diagnosis and management of suspected allergies.
Find more reporting in our Health section.
Keep reading